Adicon Holdings Limited (9860.HK) AI-Powered Stock Analysis
See how Adicon Holdings Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
9860.HK●HKSE
HealthcareMedical - Diagnostics & Research
HK$3.78
HK$0.24(5.97%)
Hong Kong Market is Open · 14:18
Adicon Holdings Limited (9860.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAdicon Holdings Limited (9860.HK) Stock Overall Grade
Adicon Holdings Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Adicon Holdings Limited's overall stock rating.
Forecast
C+Score
53/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Adicon Holdings Limited (9860.HK) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Adicon Holdings Limited stock grade, including financials, comparisons, and forecasts.